Clinical trial

A Dose-response Study With Strontium Malonate in Postmenopausal Women

NCT00409032 · Osteologix, Industry · Completed

Key facts

NCT number NCT00409032
Title A Dose-response Study With Strontium Malonate in Postmenopausal Women
Official title A Dose-response Study With Strontium Malonate in Postmenopausal Women. A 12 Week, Multi National, Double Blind, Randomized, 5 Arms, Parallel Group Placebo Controlled Open Label Active Controlled, Phase II Study With 3 Dose Levels of Strontium Malonate and Protelos Within Post Menopausal Women With a…
Lead sponsor Osteologix, Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Osteoporosis
Intervention type Drug
Interventions Strontium malonate
Enrollment 275
Start date Dec 1, 2006
Primary completion Aug 1, 2007
Completion Sep 1, 2007
First posted Dec 8, 2006
Last update posted Oct 23, 2009
Countries Denmark, United Kingdom

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies